美股市场个股详情
AQST Aquestive Therapeutics
- 5.660
- +0.170+3.10%
收盘价 10/29 16:00 (美东)
- 5.678
- +0.018+0.33%
盘前 08:08 (美东)
5.15亿总市值-15722市盈率TTM
5.670最高价5.380最低价122.00万股成交量5.500今开5.490昨收676.92万成交额1.53%换手率亏损市盈率(静)9105.98万总股本6.23052周最高-14.51市净率4.53亿流通值1.52052周最低--股息TTM7998.35万流通股20.696历史最高--股息率TTM5.28%振幅0.618历史最低5.548平均价1股每手
关于Aquestive Therapeutics公司
aququestive Therapeutics, Inc.从事识别、开发和商业化差异化产品，以解决未满足的医疗需求并解决患者的治疗问题。其产品线包括Libervant、AQST-108、AQST-305、Suboxone和Zuplenz。
公司介绍
公司代码AQST
公司名称Aquestive Therapeutics
上市日期2018/07/25
发行价格15.00
成立日期2004
CEOMr. Daniel Barber
所属市场纳斯达克
员工数量135
年结日12-31
公司地址30 Technology Drive
城市Warren
省份新泽西
国家美国
邮编07059
电话1-908-941-1900
董事高管
- 姓名
- 职务
- 年薪
- Daniel Barber
- Chief Executive Officer, President and Director
- 249.61万
- Cassie Jung
- Chief Operating Officer
- --
- Lori J. Braender
- Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
- 119.40万
- Stephen Wargacki
- Chief Science Officer
- --
- A. Ernest Toth, Jr
- Chief Financial Officer
- 111.59万
- Dr. Carl N. Kraus, M.D.
- Chief Medical Officer
- --
- A. Mark Schobel
- Chief Innovation and Technology Officer
- --
- Peter Boyd
- Senior Vice President, Information Technology, Human Resources and Communications
- --
- John S. Cochran
- Vice Chairman of the Board
- 13.72万
- Dr. Gregory B. Brown,M.D.
- Chairman of the Board
- 15.08万
- Dr. Julie Krop, M.D.
- Independent Director
- 13.77万
- Timothy E. Morris
- Independent Director
- 14.52万
- Abigail L. Jenkins, B.A.,M.S.
- Independent Director
- --
- Santo J. Costa
- Independent Director
- 20.22万
- Dr. Marco Taglietti,M.D.
- Independent Director
- 12.18万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据